Efficacy of the dust mites drops sublingual immunotherapy in pediatric allergic rhinitis.
- Author:
Lisheng XIE
;
Yinzhu JIANG
;
Qi LI
- Publication Type:Journal Article
- MeSH:
Administration, Sublingual;
Allergens;
administration & dosage;
Animals;
Antigens, Dermatophagoides;
administration & dosage;
Child;
Dermatophagoides farinae;
Desensitization, Immunologic;
Humans;
Rhinitis, Allergic;
drug therapy;
Software;
Sublingual Immunotherapy;
Treatment Outcome
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2016;30(5):357-360
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To observe the role of the dust mites drops sublingual immunotherapy(SLIT) in pediatric allergic rhiriitis caused by dust mites and compare its efficacy between monosensitized and polysensitized children.
METHOD:A total of 77 pediatric allergic rhinitis patients received Dermatophagoides farina extracts sublingual immunotherapy for 2 years were enrolled as desensitization group and were allocated into monosensitized group (41 cases) and polysensitized group (36 cases) according to the number of coexisting allergens. Meanwhile another 33 allergic rhinitis children treated by pharmacotherapy during the period were collected as control group. The total symptom scores (TNSS), total medication scores (TMS) and visual analogue scale(VAS) were assessed at the beginning, six months, 1 year and 2 years of the treatment. SPSS 13. 0 software was used to analyze the data.
RESULT:the score of TNSS and VAS in desensitization was slightly higher than the control after six months treatment, but without difference at l year and 2 years; the score of TMS had significantly improved in desensitization compared with the corresponding points in control. All the parameters in monosensitized group were equivalent with polysensitizend group, except the score of TMS was slightly lower than the polysensitizend group at six months.
CONCLUSION:Dust mite drops sublingual immunotherapy is effective for the allergic rhinitis children caused by mites. And it has similar immunotherapy efficacy between monosensitized and polysensitized children.
